Actively Recruiting
Utilizing the Michigan Neuropathy Screening Instrument, Routine Nerve Conduction Study, and Nerve Ultrasound for Early Detection of Diabetic Neuropathy
Led by Sohag University · Updated on 2024-07-30
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are comparing different methods to identify diabetic peripheral neuropathy in people recently diagnosed with type 2 diabetes. The study focuses on evaluating the Michigan Neuropathy Screening Instrument (MNSI), routine nerve conduction studies (NCS), and ultrasound of specific nerves to detect early signs of this nerve condition. This cross-sectional comparative study is conducted to find the most accurate and effective diagnostic approach for early neuropathy detection. Participants include adults aged 30 to 55 years who have been diagnosed with type 2 diabetes within the past year. The study involves using the MNSI, which includes a questionnaire, inspection, vibratory sensation testing, ankle reflex exams, and a 10 g monofilament needle examination. In addition, routine nerve conduction studies and ultrasound imaging of the median, posterior tibial, and sural nerves will be performed to assess nerve function and structure. Participants will be recruited from a diabetes clinic and will undergo these diagnostic assessments during the study visit. The main outcome measured is the early detection of diabetic neuropathy within one year of diagnosis. The study does not involve treatment but focuses on diagnostic accuracy. Participants' usual care continues as normal, and the research team will monitor the diagnostic results to compare the effectiveness of each method.
CONDITIONS
Brief Title
Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 30 to 55 years
- Diagnosis of type 2 diabetes
- Diabetes diagnosed within 1 year according to World Health Organization 1999 criteria
- Both males and females
You will not qualify if you...
- Known conditions causing neuropathy such as hereditary sensory neuropathy
- Vitamin B12 or folate deficiency
- Paraneoplastic conditions
- Autoimmune diseases
- Uremia
- Hypothyroidism
- History of ethanol abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single visit
Participants undergo assessments including the Michigan Neuropathy Screening Instrument, routine nerve conduction study, and nerve ultrasound to detect early diabetic neuropathy.
1 visit (in-person)
Duration - Not specified
Participants are observed over time to monitor for progression or changes in diabetic neuropathy.
Additional assessments may occur depending on clinical findings
Trial Site Locations
Total: 1 location
1
Faculty of medecine Sohag university
Sohag, Egypt
Actively Recruiting
Research Team
R
Reda Khalaf Allah Khalil, Resident
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here